Treatment Options for Hypogonadism (Low Testosterone)
Testosterone replacement therapy (TRT) should be considered when morning free testosterone by equilibrium dialysis is frankly low on at least 2 separate assessments, and a complete hypogonadism workup has been performed to rule out etiologies unrelated to the patient's condition. 1
Diagnostic Confirmation Before Treatment
Before initiating treatment, it's essential to:
- Confirm hypogonadism with morning total testosterone concentrations drawn between 8-10 AM on at least two separate days 1, 2
- Measure free testosterone by equilibrium dialysis and sex hormone-binding globulin levels, especially in obese patients 1
- Determine if primary (testicular) or secondary (pituitary-hypothalamic) hypogonadism by measuring LH and FSH levels 1
- For secondary hypogonadism, consider additional testing including serum prolactin, iron saturation, pituitary function tests, and MRI of the sella turcica 1
Treatment Options
1. Transdermal Testosterone Preparations (First-Line)
Gels (1% or 1.62%): Applied daily to shoulders and upper arms 2, 3
- Advantages: Stable day-to-day testosterone levels, convenient application 1
- Dosing: Start with 40.5 mg (2 pump actuations or single 40.5 mg packet) applied once daily 3
- Dose adjustments based on serum levels:
750 ng/dL: Decrease daily dose by 20.25 mg
- 350-750 ng/dL: No change
- <350 ng/dL: Increase daily dose by 20.25 mg 3
Patches: Applied daily to skin
2. Injectable Testosterone
- Testosterone Enanthate/Cypionate: Intramuscular injections
3. Implantable Testosterone Pellets
- Advantages: Long-term option, avoiding daily administration 1
- Disadvantages: Requires implantation procedure 1
4. Alternative Therapies
- Clomiphene Citrate: For men who wish to preserve fertility
Monitoring
- Test testosterone levels 2-3 months after treatment initiation and after any dose changes 2
- Once stable, monitor every 6-12 months 1, 2
- For injectable testosterone, measure levels midway between injections 1
- Monitor hematocrit/hemoglobin and PSA regularly 2
- Target testosterone levels: 450-600 ng/dL (mid-normal range) 2
Benefits of Treatment
- Increased lean muscle mass and reduced body fat 2, 5
- Improved sense of well-being and energy levels 2, 5
- Enhanced sexual function and libido 2, 5
- Improved bone density and reduced fracture risk 2
- Improved mood 5
Safety Considerations and Contraindications
Contraindications: Prostate cancer, male breast cancer, desire for near-term fertility, severe sleep apnea, uncontrolled heart failure, hematocrit >54% 2
Potential Adverse Effects:
- Erythrocytosis (dose-dependent: 2.8-17.9%) 2
- Fluid retention (caution in heart failure or renal insufficiency) 2, 6
- Skin reactions with transdermal preparations 2
- Risk of secondary exposure with gels (risk of virilization in women and children) 3
- Potential cardiovascular effects (long-term safety uncertain) 2
- Suppression of spermatogenesis 2
Special Caution:
Clinical Pearls
- Transdermal testosterone is safer for patients with liver concerns compared to oral formulations 2
- Application site matters: arms/shoulders > chest/abdomen > legs for absorption 7
- Proper patient education is crucial regarding application technique, risk of transfer, and long-term therapy expectations 2
- Weight loss and lifestyle modifications should be considered as complementary approaches, especially in obese patients 2
The choice of testosterone preparation should consider the patient's preference, cost considerations, and specific clinical factors, with transdermal preparations being the most commonly recommended first-line option due to their favorable pharmacokinetic profile and ease of use.